European equities traded in the US as American depositary receipts were trending sharply higher late Wednesday morning, rising 1.72% to 1,443.47 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company Grifols (GRFS) and financial services company Banco Bilbao Vizcaya Argentaria (BBVA), which rose 5.2% and 4.6% respectively. They were followed by biopharmaceutical company Genfit (GNFT) and financial services company ING Groep (ING), which were up 4.3% and 4.1% respectively.
The decliners from continental Europe were led by accommodations booking site trivago (TRVG) and furniture maker Natuzzi (NTZ), which dropped 5.4% and 2.8% respectively. They were followed by petroleum refiner Equinor (EQNR) and biotech firm Evaxion Biotech (EVAX), which were down 1.2% and 0.5% respectively.
From the UK and Ireland, the gainers were led by biotech company Autolus Therapeutics (AUTL) and alcoholic beverage company Diageo (DEO), which climbed 8.6% and 4.9% respectively. They were followed by insurance provider Prudential (PUK) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which increased 4.6% each.
The decliners from the UK and Ireland were led by biopharmaceutical company TC Biopharm (TCBP) and utilities company National Grid (NGG), which fell 8.2% and 2.5% respectively. They were followed by educational publisher Pearson (PSO) and hospitality company InterContinental Hotels (IHG), which lost 1.8% and 0.6% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。